Vijay Iyer, Nadeen N Faza, Michael Pfeiffer, Mark Kozak, Brandon Peterson, Mortiz Wyler von Ballmoos, Sarah Mollenkopf, Melissa Mancilla, Diandra Latibeaudiere-Gardner, Michael J Reardon
UNLABELLED: Background. Tricuspid regurgitation (TR) is a high-prevalence disease associated with poor quality of life and mortality. This quantitative patient preference study aims to identify TR patients' perspectives on risk-benefit tradeoffs. Methods. A discrete-choice experiment was developed to explore TR treatment risk-benefit tradeoffs. Attributes (levels) tested were treatment (procedure, medical management), reintervention risk (0%, 1%, 5%, 10%), medications over 2 y (none, reduce, same, increase), shortness of breath (none/mild, moderate, severe), and swelling (never, 3× per week, daily)...
2024: MDM Policy & Practice